The presence of sub-clinical systemic inflammation in the T2DM subjects of our study was also confirmed by increased PAI-1 levels as well as by resistin, which was significantly raised in T2DM men. The gene discussed is SERPINE1; the disease is type 2 diabetes mellitus.